Endocrine dysfunction in sepsis: A beneficial or deleterious host response?

GERMS

Volumn 5, Issue 1, 2015, Pages 17-25

  Gheorghiţă, Valeriu ^a,b   Barbu, Alina Elena ^b   Gheorghiu, Monica Livia ^c,d   Căruntu, Florin Alexandru ^a,c  

^a Central Military Hospital Bucharest   (Romania)

^b Professor Dr Matei Bals National Institute of Infectious Diseases   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

Author keywords

Endocrine dysfunction; Hormones; Host response; Inflammation; Sepsis

Indexed keywords

ARGIPRESSIN; COPEPTIN; CORTICOTROPIN; CYTOKINE; GAMMA INTERFERON; HYDROCORTISONE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; NORADRENALIN; OXYGEN RADICAL; PROTIRELIN; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

AUTONOMIC NERVOUS SYSTEM; ENDOCRINE DISEASE; ENDOTHELIAL DYSFUNCTION; EUTHYROID SICK SYNDROME; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERLEPTINEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNE SYSTEM; INSULIN RESISTANCE; MULTIPLE ORGAN FAILURE; NEUROENDOCRINE SYSTEM; NEUROHYPOPHYSIS; NONHUMAN; PATHOGENESIS; REVIEW; SEPSIS; VAGUS NERVE;

EID: 84924228817     PISSN: None     EISSN: 22482997     Source Type: Journal    
DOI: 10.11599/germs.2015.1067     Document Type: Review

References (42)

1. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 2013;41:580-637. [CrossRef] [PubMed]
2. Chen M, Wang B, Xu Y, et al. Diagnostic value of serum leptin and a promising novel diagnostic model for sepsis. Exp Ther Med 2014;7:881-6. [PubMed] [FullText]
3. Munford RS, Tracey KJ. Is severe sepsis a neuroendocrine disease? Mol Med 2002;8:437-42. [PubMed] [FullText]
4. Sharshar T, Hopkinson NS, Orlikowski D, Annane D. Science review: The brain in sepsis - culprit and victim. Crit Care 2005;9:37-44. [CrossRef] [PubMed] [FullText]
5. Choong K. Hormonal therapies in severe sepsis. In: Severe sepsis and septic shock - understanding a serious killer, Ed: Fernandez R, InTech, p 359-78. [CrossRef]
6. Khardori R, Castillo D. Endocrine and metabolic changes during sepsis: an update. Med Clin North Am 2012;96:1095-105. [CrossRef] [PubMed]
7. Katan M, Christ-Crain M. The stress hormone copeptin: a new prognostic biomarker in acute illness. Swiss Med Wkly 2010;140:w13101. [PubMed]
8. Van der Berghe G, de Zegher F, Bouillon R. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998;83:1827-34. [PubMed]
9. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003;348:727-34. [CrossRef] [PubMed]
10. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008;36:1937-49. [CrossRef] [PubMed]
11. Menon K, Ward RE, Lawson ML, et al. A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med 2010;182:246-51. [CrossRef] [PubMed]
12. Tordman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, Stern N. Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test. Clin Endocrinol (Oxf) 2000;52:633-40. [CrossRef] [PubMed]
13. Lipiner-Frieman D, Sprung CL, Laterre PF, et al. Adrenal function in sepsis: the retrospective Corticus study. Crit Care Med 2007;35:1012-8. [CrossRef] [PubMed]
14. Struck J, Morgenthaler NG, Bergmann A. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 2005;26:2500-04. [CrossRef] [PubMed]
15. Palmiere C, Augsburger M. Copeptin as a diagnostic biomarker for sepsis-related deaths. Peptides 2014;59:75-8. [CrossRef] [PubMed]
16. Russell JA. Bench-to-bedside review: Vasopressin in the management of septic shock. Crit Care 2011;15:226. [CrossRef] [PubMed] [FullText]
17. Morgenthaler NG, Struck J, Jochberger S, Dünser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 2008;19:43-9. [CrossRef] [PubMed]
18. Wilson MF, Brackett DJ, Tompkins P, Benjamin B, Archer LT, Hinshaw LB. Elevated plasma vasopressin concentrations during endotoxin and E. coli shock. Adv Shock Res 1981;6:15-26. [PubMed]
19. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87. [CrossRef] [PubMed]
20. Latronico N, Castioni CA. Copeptin in critical illness. Clin Chem Lab Med 2014;52:1391-93. [CrossRef] [PubMed]
21. Barat C, Simpson L, Breslow E. Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus. Biochemistry 2004;43:8191-203. [CrossRef] [PubMed]
22. Morgenthaler NG, Müller B, Struck J, Bergmann A, Redl H, Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007;28:219-26. [CrossRef] [PubMed]
23. Ho J, Al-Musalhi H, Chapman M, et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 2006;91:105-14. [CrossRef] [PubMed]
24. Arafah BM. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab 2006;91:3725-45. [CrossRef] [PubMed]
25. Minneci PC, Deans KJ, Eichacker PQ, Natanson C. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect 2009;15:308-18. [CrossRef] [PubMed] [FullText]
26. Koh GCKW, Peacock SJ, van der Poll T, Wiersinga WJ. The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis 2012;31:379-88. [CrossRef] [PubMed][FullText]
27. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care 2006;12:315-21. [CrossRef] [PubMed]
28. Krinsley JS, Fisher M. The diabetes paradox: diabetes is not independently associated with mortality in critically ill patients. Hosp Pract (1995) 2012;40:31-5. [CrossRef] [PubMed]
29. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-82. [CrossRef] [PubMed]
30. Brunkhorst F, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39. [CrossRef] [PubMed]
31. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus Conventional Glucose Control in Critically Ill Patients. N Engl J Med 2009;360:1283-97. [CrossRef] [PubMed]
32. Devos P, Preiser JC, Melot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycemia: final results of the Glucontrol study. Intensive Care Med 2007;33:S189.
33. Paz-Filho G, Mastronardi C, Franco BC, Wang KB, Wong ML, Licinio J. Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications. Arq Bras Endocrinol Metab 2012;56:597-607. [CrossRef] [PubMed]
34. Shapiro NI, Khankin EV, Van Meurs M, et al. Leptin exacerbates sepsis-mediated morbidity and mortality. J Imunol 2010;185:517-24. [CrossRef] [PubMed] [FullText]
35. Behnes M, Brueckmann M, Lang S, et al. Alterations of leptin in the course of inflammation and severe sepsis. BMC Infect Dis 2012;12:217. [CrossRef] [PubMed] [FullText]
36. Koch A, Weiskirchen R, Zimmermann HW, Sanson E, Trautwein C, Tacke F. Relevance of serum leptin and leptin-receptor concentrations in critically ill patients. Mediators Inflamm 2010;2010:473540. [CrossRef] [PubMed][FullText]
37. Lam QL, Lu L. Role of leptin in immunity. Cell Mol Immunol 2007;4:1-13. [PubMed]
38. Bracho-Riquelme RL, Reyes-Romero MA. Leptin in sepsis: a well-suited biomarker in critically ill patients? Crit Care 2010;14:138. [CrossRef] [PubMed][FullText]
39. Yousef AA, Amr YM, Suliman GA. The diagnostic value of serum leptin monitoring and its correlation with tumour necrosis factor-alpha in critically ill patients: a prospective observational study. Crit Care 2010;14:R33. [CrossRef] [PubMed][FullText]
40. Sharma S, Dabla PK, Kumar S, Dublis S. Thyroid hormone dysfunction and CRP levels in neonates with sepsis. J Endocrinol Metab 2013;3:62-6.
41. Angelousi AG, Karageorgopoulos DE, Kapaskelis AM, Falagas ME. Association between thyroid function test at baseline and the outcome of patients with sepsis or septic shock: a systematic review. Eur J Endocrinol 2011;164:147-55. [CrossRef] [PubMed]
42. Zuppa AF, Nadkarni V, Davis L, et al. The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med 2004;32:2318-22. [PubMed]